Started in Oxford

Since 1997, Oxford University Innovation has been responsible for creating spin-out companies based on academic research generated within and owned by the University of Oxford, and has spun-out a new company every two months on average.

Over £266 million in external investment has been raised by Oxford University Innovation spinouts since 2000, and five are currently listed on London’s AIM market.

The creation of these new spin-out companies also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.

Companies by University of Oxford Department

Centre for Cellular and Molecular Physiology

ReOx is a drug discovery company that is building on the primary research of the founding academics to develop novel treatments for disease by controlling the activity of hypoxia inducible factor (HIF).

Incorporated in May 2003

Origin: Oxford University, Centre for Cellular and Molecular Physiology

Chemistry

Specialise in applying state-of-the-art mass spectrometry platforms to characterising intact protein assemblies, often referred to as native mass spectrometry.

Incorporated in March 2016

Origin: Oxford University, Chemistry

Researches, designs and will market diagnostic tests for the measurement of clinical bio markers that reduce healthcare costs and improve patient outcomes.

Incorporated in June 2016

Origin: Oxford University, Chemistry

Department of Biochemistry

Crysalin develop a protein lattice technology that is founded on a novel form of highly ordered materials, crysalins, that are produced through modification of naturally occurring protein building blocks.

Incorporated in June 2007

Origin: Oxford University, Department of Biochemistry

Department of Cardiovascular Medicine

Developing solutions for major unmet needs in diagnostic medicine in multiple internal organs. In the first instance the focus will be on, the detection and the accurate, quantitative measurement of liver, gallbladder and pancreatic disease, including precancerous and cancerous states in these organs.

Incorporated in April 2013

Origin: Oxford University, Department of Cardiovascular Medicine

Department of Chemistry

At OxSyBio, we are developing 3D printing techniques to produce a range of tissue-like and functional tissues for medical research and clinical applications. Our vision is to ultimately produce tissues that can be used in the clinic for organ repair or replacement. Professor Bayley’s group have previously demonstrated the ability to print three-dimensional networks comprising tens of thousands of picoliter aqueous droplets forming a cohesive material. These networks can be built in software-controlled geometries using a number of different droplet types, thus enabling them to perform simple cell-like functions and act as ‘tissue-like’ materials. Initial work showed that printed networks were capable of conducting electrical signals along neuron-like pathways by the selective incorporation of membrane proteins, or to fold in a pre-defined manner to assume altered shapes after printing. OxSyBio is refining and advancing this technology to print more complex networks more rapidly and at a higher resolution. We are also adapting the approach to print living cells inside droplets, which will enable the direct printing of 3D cell networks with many of the characteristics of living tissues.

Incorporated in April 2014

Origin: Oxford University, Department of Chemistry

Oxidative Enzymes for the Pulp and Paper Industry.

Incorporated in February 2010

Origin: Oxford University, Department of Chemistry

Oxtox develops medical devices for the detection of specific drugs in the human system.

Incorporated in November 2006

Origin: Oxford University, Department of Chemistry

Oxford Advanced Surfaces develops and commercialises advanced materials and technology solutions leveraging breakthrough surface modification technology.

Incorporated in September 2006

Origin: Oxford University, Department of Chemistry

Oxford Nanopore Technologies is developing and commercialising a new generation of nanopore-based electronic systems for analysis of single molecules, including DNA, RNA and proteins.

Incorporated in May 2005

Origin: Oxford University, Department of Chemistry

Department of Classics

Develops and manufacturers multispectral digital scanners based upon a patented flatbed scanner design.

Incorporated in September 2011

Origin: Oxford University, Department of Classics

Department of Computer Science

OxCept is a team of security and communication experts creating military-grade authentication security products for business teams.

Incorporated in January 2014

Origin: Oxford University, Department of Computer Science

Domain-centric intelligent automated data extraction methodology.

Incorporated in February 2015

Origin: Oxford University, Department of Computer Science

A revolutionary new approach to indoor positioning that combines data from mobile phone sensors with map information such as floor plans, and wifi “maps” where available, to give highly accurate location information without the need for any further hardware.

Incorporated in December 2015

Origin: Oxford University, Department of Computer Science

SemmleCode is a line of products aimed to help developer teams improve their software quality.

Incorporated in March 2008

Origin: Oxford University, Department of Computer Science

DiffBlue is a world leader in automated test generation. Their products have been developed with industry partners over the last ten years and replace the manual process of writing tests.

Incorporated in March 2016

Origin: Oxford University, Department of Computer Science

Department of Earth Sciences

EKB Technology commercialises a revolutionary Bioprocessing Technology developed for the use of biological systems such as plant and animal cells and microorganisms to modify, produce or purify chemical intermediates.

Incorporated in December 2004

Origin: Oxford University, Department of Earth Sciences

Department of Engineering Science

Deontics is software which guides doctors and patients through the scientific and clinical decision making.

Incorporated in August 2015

Origin: Oxford University, Department of Engineering Science

The OxEML system uses electromagnetic and acoustic waves to create a new class of medical images at a cost comparable to ultrasound.

Incorporated in October 2015

Origin: Oxford University, Department of Engineering Science

Oxford Flow’s industrial pressure regulators use innovative technology to provide new levels of performance for natural gas transmission, water distribution and process industries.

Incorporated in September 2015

Origin: Oxford University, Department of Engineering Science

Developing domestic energy storage capacity and facilitating its operation within the existing power distribution infrastructure.

Incorporated in April 2015

Origin: Oxford University, Department of Engineering Science

Developing tiny metallic mesh tube devices to treat patients suffering from brain aneurysms

Incorporated in December 2015

Origin: Oxford University, Department of Engineering Science

A software that uses advanced algorithms and techniques to solve problems

Incorporated in February 2016

Origin: Oxford University, Department of Engineering Science

Kepler Energy Limited develops a second-generation tidal turbine, which has the potential to harness tidal energy more efficiently and cheaply, using a device which is simpler, more robust and more scalable than current designs.

Incorporated in October 2010

Origin: Oxford University, Department of Engineering Science

Oxford Electromagnetic Solutions - smart asset management through underground network visibility.

Incorporated in June 2010

Origin: Oxford University, Department of Engineering Science

YASA Motors manufactures a highly differentiated advanced axial flux motor and generator based on its proprietary Yokeless And Segmented Armature (YASA™) technology.

Incorporated in August 2009

Origin: Oxford University, Department of Engineering Science

Navetas is a UK based technology company delivering cloud-based energy monitoring and smart data analytics for the connected home.

Incorporated in November 2008

Origin: Oxford University, Department of Engineering Science

Aurox was established to research, develop, manufacture and commercially exploit products in the field of confocal microscopy and automated pathology slide scanners.

Incorporated in July 2006

Origin: Oxford University, Department of Engineering Science

Particle Therapeutics is a drug delivery company developing innovative particle formulation and drug delivery technologies to improve the efficacy and administration of a range of pharmaceuticals.

Incorporated in June 2006

Origin: Oxford University, Department of Engineering Science

Department of Inorganic Chemistry

Velocys, previously Oxford Catalysts, produces speciality catalysts for the generation of clean fuels, from both conventional fossil fuels and renewable sources such as biomass.

Incorporated in December 2005

Origin: Oxford University, Department of Inorganic Chemistry

Department of Materials

Designer Carbon Materials, Developing advanced nanomaterials for a range of applications, including energy harvesting, bio-sensing and quantum nanoelectronics.

Incorporated in April 2014

Origin: Oxford University, Department of Materials

Using phase change materials for smart glazing and displays.

Incorporated in November 2015

Origin: Oxford University, Department of Materials

Developing high performance scientific imaging detectors capable of studying structures and processes at the atomic level.

Incorporated in October 2011

Origin: Oxford University, Department of Materials

Department of Mathematics/Oxford e-Research Centre

Incorporated in March 2009

Origin: Oxford University, Department of Mathematics/Oxford e-Research Centre

Department of Oncology

Department of Organic Chemistry

Summit Therapeutics is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat the fatal muscle wasting disease Duchenne muscular dystrophy and infections caused by the bacteria C. difficile.

Incorporated in February 2003

Origin: Oxford University, Department of Organic Chemistry

Department of Pathology

BioAnalab offers a contract testing service to the biopharmaceutical industry for the rapidly growing area of therapeutic monoclonal antibodies, with a longer-term strategy to develop diagnostics to measure levels of monoclonal antibodies and their immune response. In July 2009, BioAnaLab was acquired by Millipore Corp.

Incorporated in November 2002

Origin: Oxford University, Department of Pathology

Department of Pharmacology

G-Nostics has identified SNPs that have highly predictive associations with nicotine addiction and therefore tobacco consumption. These SNPs provide a method to help individuals decide which specific smoking cessation methods are most effective for them, offering personalised treatment to the 'smoker' which significantly increases their chances of quitting.

Incorporated in June 2004

Origin: Oxford University, Department of Pharmacology

Department of Physical and Theoretical Chemistry

Oxford Medical Diagnostics develops and supplies breath analysis technologies for rapid, accurate, and low-cost monitoring of diseases and metabolic functions.

Incorporated in June 2004

Origin: Oxford University, Department of Physical and Theoretical Chemistry

Department of Physics

Department of Physiology, Anatomy and Genetics

TdeltaS is committed to developing science-based proprietary products that sit at the interface of food and pharmaceuticals - nutraceuticals - and offer real improvement in human physical and mental performance.

Incorporated in March 2006

Origin: Oxford University, Department of Physiology, Anatomy and Genetics

Department of Social Policy and Intervention

Department of Surgical Sciences

A biotechnology company formed to research and develop novel medicines from natural sources for the treatment of immune-mediated and inflammatory diseases.

Incorporated in November 2010

Origin: Oxford University, Department of Surgical Sciences

Department of Zoology

AnDy marries fine-engineering skills with a deep understanding of the fundamental mechanisms, to produce revolutionary machines that will change the shape of the future, taking inspiration from our environment in order to protect it, and capable of performance beyond anything currently found in nature or engineering.

Incorporated in April 2015

Origin: Oxford University, Department of Zoology

Division of Clinical Neurology/Weatherall Institute of Molecular Medicine

Cytox develops a technology platform for tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias.

Incorporated in October 2006

Origin: Oxford University, Division of Clinical Neurology/Weatherall Institute of Molecular Medicine

Engineering

Engineering/ Pathology

Institute of Biomedical Engineering

Intelligent Ultrasound develops and sells products and services that make medical ultrasound imaging a more effective diagnostic tool and help hospitals provide a better quality, more consistent ultrasound imaging service for their patients.

Incorporated in July 2012

Origin: Oxford University, Institute of Biomedical Engineering

Using leading edge human biomimetic platforms to test and develop therapeutics for serious human diseases.

Incorporated in July 2009

Origin: Oxford University, Institute of Biomedical Engineering

Institute of Biomedical Engineering/Nuffield Department of Surgical Sciences

The OrganOx metra is the first and only fully automated normothermic liver perfusion device for improved organ preservation. The OrganOx pipeline products will extend the use of their core technology to the preservation of other organs.

Incorporated in November 2008

Origin: Oxford University, Institute of Biomedical Engineering/Nuffield Department of Surgical Sciences

Jenner Institute

Neuroscience

EvOx Therapeutics harnesses the body’s own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune diseases and cancers.

Incorporated in April 2016

Origin: Oxford University, Neuroscience

The OxSight ‘SmartSpecs’ help sight impaired and blind people to navigate independently, avoid collisions and see in the dark.

Incorporated in June 2016

Origin: Oxford University, Neuroscience

Nuffield Department of Clinical Medicine

Oxford Immunotec is a global, commercial-stage diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology.

Incorporated in October 2002

Origin: Oxford University, Nuffield Department of Clinical Medicine

Nuffield Department of Clinical Neurosciences

Nuffield Department of Population Health

Oxford Risk is the market-leading provider of customer risk profilers. Their products reveal the level of risk customers are willing and able to take with their financial investments.

Incorporated in November 2002

Origin: Oxford University, Nuffield Department of Population Health

Nuffield Division of Clinical and Laboratory Sciences

ClinOx offers clients knowledge and expertise in the development, placement, conduct and analysis of early phase oncology clinical trials, with particular emphasis on pharmacokinetic and mechanistic endpoints.

Incorporated in June 2007

Origin: Oxford University, Nuffield Division of Clinical and Laboratory Sciences

Ophthalmology

Circadian Therapeutics identify and bring to market pharmaceutical and diagnostic platforms for the effective management of physiological and pathological conditions through their ability to modify the body's circadian rhythms.

Incorporated in September 2016

Origin: Oxford University, Ophthalmology

Pharmacology

Physics

Oxford Nanoimaging’s microscope, the Nanoimager, is a single-molecule fluorescence microscope. It is about 30 times smaller and significantly less expensive than current super-resolution microscopes and will be manufactured in the UK.

Incorporated in May 2016

Origin: Oxford University, Physics

Psychiatry

Virtual Reality software to help treat people with severe paranoia by allowing them to face situations that they fear.

Incorporated in December 2016

Origin: Oxford University, Psychiatry

Radcliffe Department of Medicine

Developing a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford’s Weatherall Institute of Molecular Medicine.

Incorporated in July 2015

Origin: Oxford University, Radcliffe Department of Medicine

Science and Technology Facilities Council

Advanced materials and technologies in safe, lightweight, high performance hydrogen storage technology.

Incorporated in January 2011

Origin: Oxford University, Science and Technology Facilities Council

Sir William Dunn School of Pathology

Data discovery software to manage and sort collections of images and data visually

Incorporated in January 2016

Origin: Oxford University, Sir William Dunn School of Pathology

Weatherall Institute of Molecular Medicine

Cellular immunity vaccines.

Incorporated in September 2012

Origin: Oxford University, Weatherall Institute of Molecular Medicine

Wellcome Trust Centre for Human Genetics

Develop cutting edge software applications that uncover the relationships between genetic variation and human disease. Help pharmaceutical companies de-risk the drug development process.

Incorporated in March 2014

Origin: Oxford University, Wellcome Trust Centre for Human Genetics

Surface Therapeutics is a drug discovery and development company developing innovative new drugs to treat inflammatory epithelial diseases of the skin and lungs. Surface Therapeutics was acquired by Serentis Inc in September 2007.

Incorporated in November 2004

Origin: Oxford University, Wellcome Trust Centre for Human Genetics

A biotherapeutics company, established to exploit the work in Viral Hepatitis undertaken at Imperial College, London and at Oxford University through the Wellcome Trust Centre for Human Genetics.

Incorporated in July 2003

Origin: Oxford University, Wellcome Trust Centre for Human Genetics

Search

Ready to get in touch?

Contact Us
Search
© Oxford University Innovation